Wade Julia, Farrar Nicola, Realpe Alba X, Donovan Jenny L, Forsyth Laura, Harkness Kirsty A, Hutchinson Peter J A, Kitchen Neil, Lewis Steff C, Loan James J M, Stephen Jacqueline, Al-Shahi Salman Rustam
Bristol Medical School, University of Bristol, 39 Whatley Road, Bristol, BS8 2PS, UK.
Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, NINE Edinburgh BioQuarter, 9 Little France Road, EH16 4UK, UK.
EClinicalMedicine. 2024 Apr 18;71:102557. doi: 10.1016/j.eclinm.2024.102557. eCollection 2024 May.
It was anticipated that recruitment to the Cavernous malformations: A Randomised Effectiveness (CARE) pilot randomised trial would be challenging. The trial compared medical management and surgery (neurosurgical resection or stereotactic radiosurgery) with medical management alone, for people with symptomatic cerebral cavernous malformation (ISRCTN41647111). Previous trials comparing surgical and medical management for intracranial vascular malformations failed to recruit to target. A QuinteT Recruitment Intervention was integrated during trial accrual, September 2021-April 2023 inclusive, to improve informed consent and recruitment.
The QuinteT Recruitment Intervention combined iterative collection and analysis of quantitative data (28 trial site screening logs recording numbers/proportions screened, eligible, approached and randomised) and qualitative data (79 audio-recorded recruitment discussions, 19 interviews with healthcare professionals, 11 interviews with patients, 2 investigator workshops, and observations of study meetings, all subject to thematic, content or conversation analysis). We triangulated quantitative and qualitative data to identify barriers and facilitators to recruitment and how and why these arose. Working with the chief investigators and trial management group, we addressed barriers and facilitators with corresponding actions to improve informed consent and recruitment.
Barriers identified included how usual care practices made equipoise challenging, multi-disciplinary teams sometimes overrode recruiter equipoise and logistical issues rendered symptomatic cavernoma diagnosis and assessment for stereotactic radiosurgery challenging. Facilitators identified included the preparedness of some neurosurgeons' to offer surgery to people otherwise offered medical management alone, multi-disciplinary team equipoise, and effective information provision presenting participation as a solution to equipoise regarding management. Actions, before and during recruitment, to improve inclusivity of site screening, approach and effectiveness of information provision resulted in 72 participants recruited following a 5-month extension, exceeding the target of 60 participants.
QuinteT Recruitment Intervention insights revealed barriers and facilitators, enabling identification of remedial actions. Recruitment to a definitive trial would benefit from further training/support to encourage clinicians to be comfortable approaching patients to whom medical management is usually offered, and broadening the pool of neurosurgeons and multi-disciplinary team members prepared to offer surgery, particularly stereotactic radiosurgery.
National Institute for Health and Care Research.
预计海绵状血管畸形:随机有效性(CARE)试点随机试验的招募工作将具有挑战性。该试验比较了药物治疗与手术治疗(神经外科切除术或立体定向放射外科手术)联合单纯药物治疗,用于有症状的脑海绵状血管畸形患者(国际标准随机对照试验编号:ISRCTN41647111)。先前比较颅内血管畸形手术治疗和药物治疗的试验未能达到招募目标。在2021年9月至2023年4月(含)的试验招募期间,采用了QuinteT招募干预措施,以改善知情同意和招募情况。
QuinteT招募干预措施结合了定量数据(28份试验站点筛选日志,记录筛选、符合条件、接触和随机分组的人数/比例)和定性数据(79次录音招募讨论、19次对医疗保健专业人员的访谈、11次对患者的访谈、2次研究者研讨会以及对研究会议的观察,所有这些都进行了主题、内容或对话分析)的迭代收集和分析。我们对定量和定性数据进行三角测量,以确定招募的障碍和促进因素,以及这些因素如何产生和为何产生。与首席研究员和试验管理小组合作,我们采取相应行动解决障碍和促进因素,以改善知情同意和招募情况。
确定的障碍包括常规护理做法如何使 equipoise 具有挑战性、多学科团队有时会推翻招募者的 equipoise 以及后勤问题使有症状海绵状血管瘤的诊断和立体定向放射外科手术评估具有挑战性。确定的促进因素包括一些神经外科医生愿意为原本只接受药物治疗的患者提供手术、多学科团队的 equipoise 以及有效的信息提供,将参与呈现为解决管理方面 equipoise 的一种方法。在招募前和招募期间采取的行动,以提高站点筛选的包容性、信息提供的方式和有效性,在延长5个月后招募了72名参与者,超过了60名参与者的目标。
QuinteT招募干预措施的见解揭示了障碍和促进因素,从而能够确定补救行动。确定性试验的招募将受益于进一步的培训/支持,以鼓励临床医生更自在地接触通常接受药物治疗的患者,并扩大愿意提供手术,特别是立体定向放射外科手术的神经外科医生和多学科团队成员的范围。
国家卫生与保健研究所。